INVESTIGATION OF CO-TRIMOXAZOLE EFFICIENCY USING THE EXPERIMENTAL TUBERCULOSIS MODEL IN MICE CAUSED BY TUBERCULOUS MYCOBACTERIA WITH EXTENSIVE DRUG RESISTANCE

The efficiency of using co-trimoxazole for treatment of mice infected with tuberculous mycobacteria with extensive drug resistance and supposed sensitivity to co-trimoxazole have been investigated.The study of 78 clinical cultures of tuberculous mycobacteria has demonstrated that drug resistance to...

Full description

Bibliographic Details
Main Authors: S. A. Popov, G. N. Mozhokina, S. A. Kosenkov, N. A. Elistratova, T. P. Sabgayda
Format: Article
Language:Russian
Published: New Terra Publishing House 2017-02-01
Series:Туберкулез и болезни лёгких
Subjects:
Online Access:https://www.tibl-journal.com/jour/article/view/976
_version_ 1797703521841184768
author S. A. Popov
G. N. Mozhokina
S. A. Kosenkov
N. A. Elistratova
T. P. Sabgayda
author_facet S. A. Popov
G. N. Mozhokina
S. A. Kosenkov
N. A. Elistratova
T. P. Sabgayda
author_sort S. A. Popov
collection DOAJ
description The efficiency of using co-trimoxazole for treatment of mice infected with tuberculous mycobacteria with extensive drug resistance and supposed sensitivity to co-trimoxazole have been investigated.The study of 78 clinical cultures of tuberculous mycobacteria has demonstrated that drug resistance to first line drugs (cases with multiple drug resistance – MDR) can be accompanied by the expansion of polymorphism in the part of drug susceptibility to co-trimoxazole, thus this drug can be used as an additional drug in the treatment of M/XDR tuberculosis patients. Using co-trimoxazole as an additional drug to isoniazid in the model of generalized tuberculosis in mice infected with Beijing strain with XDR reduced the bacterial load of the lungs by 10 times.Detail evaluation of drug susceptibility/resistance of tuberculous mycobacteria to the additional drug of co-trimoxazole and investigation of the interaction of this drug with other agents included into treatment regimens IV and V can form the basis for improvement of treatment regimens for M/XDR tuberculosis patients with specification of doses and frequency of drug in-takes for each specific case.
first_indexed 2024-03-12T05:05:45Z
format Article
id doaj.art-78c22f594bac47ad8814bf78ae11be81
institution Directory Open Access Journal
issn 2075-1230
2542-1506
language Russian
last_indexed 2024-03-12T05:05:45Z
publishDate 2017-02-01
publisher New Terra Publishing House
record_format Article
series Туберкулез и болезни лёгких
spelling doaj.art-78c22f594bac47ad8814bf78ae11be812023-09-03T08:57:17ZrusNew Terra Publishing HouseТуберкулез и болезни лёгких2075-12302542-15062017-02-01952515810.21292/2075-1230-2017-95-2-51-58976INVESTIGATION OF CO-TRIMOXAZOLE EFFICIENCY USING THE EXPERIMENTAL TUBERCULOSIS MODEL IN MICE CAUSED BY TUBERCULOUS MYCOBACTERIA WITH EXTENSIVE DRUG RESISTANCES. A. Popov0G. N. Mozhokina1S. A. Kosenkov2N. A. Elistratova3T. P. Sabgayda4НИИ фтизиопульмонологии ФГБОУ ВО «Первый МГМУ им. И. М. Сеченова» МЗ РФНИИ фтизиопульмонологии ФГБОУ ВО «Первый МГМУ им. И. М. Сеченова» МЗ РФНИИ фтизиопульмонологии ФГБОУ ВО «Первый МГМУ им. И. М. Сеченова» МЗ РФНИИ фтизиопульмонологии ФГБОУ ВО «Первый МГМУ им. И. М. Сеченова» МЗ РФНИИ фтизиопульмонологии ФГБОУ ВО «Первый МГМУ им. И. М. Сеченова» МЗ РФ; ФГБУ «Центральный НИИ организации и информатизации здравоохранения» МЗ РФThe efficiency of using co-trimoxazole for treatment of mice infected with tuberculous mycobacteria with extensive drug resistance and supposed sensitivity to co-trimoxazole have been investigated.The study of 78 clinical cultures of tuberculous mycobacteria has demonstrated that drug resistance to first line drugs (cases with multiple drug resistance – MDR) can be accompanied by the expansion of polymorphism in the part of drug susceptibility to co-trimoxazole, thus this drug can be used as an additional drug in the treatment of M/XDR tuberculosis patients. Using co-trimoxazole as an additional drug to isoniazid in the model of generalized tuberculosis in mice infected with Beijing strain with XDR reduced the bacterial load of the lungs by 10 times.Detail evaluation of drug susceptibility/resistance of tuberculous mycobacteria to the additional drug of co-trimoxazole and investigation of the interaction of this drug with other agents included into treatment regimens IV and V can form the basis for improvement of treatment regimens for M/XDR tuberculosis patients with specification of doses and frequency of drug in-takes for each specific case.https://www.tibl-journal.com/jour/article/view/976экспериментальный туберкулез у мышейтуберкулез с млу/шлу возбудителялекарственная чувствительность m. tuberculosis к ко-тримоксазолу
spellingShingle S. A. Popov
G. N. Mozhokina
S. A. Kosenkov
N. A. Elistratova
T. P. Sabgayda
INVESTIGATION OF CO-TRIMOXAZOLE EFFICIENCY USING THE EXPERIMENTAL TUBERCULOSIS MODEL IN MICE CAUSED BY TUBERCULOUS MYCOBACTERIA WITH EXTENSIVE DRUG RESISTANCE
Туберкулез и болезни лёгких
экспериментальный туберкулез у мышей
туберкулез с млу/шлу возбудителя
лекарственная чувствительность m. tuberculosis к ко-тримоксазолу
title INVESTIGATION OF CO-TRIMOXAZOLE EFFICIENCY USING THE EXPERIMENTAL TUBERCULOSIS MODEL IN MICE CAUSED BY TUBERCULOUS MYCOBACTERIA WITH EXTENSIVE DRUG RESISTANCE
title_full INVESTIGATION OF CO-TRIMOXAZOLE EFFICIENCY USING THE EXPERIMENTAL TUBERCULOSIS MODEL IN MICE CAUSED BY TUBERCULOUS MYCOBACTERIA WITH EXTENSIVE DRUG RESISTANCE
title_fullStr INVESTIGATION OF CO-TRIMOXAZOLE EFFICIENCY USING THE EXPERIMENTAL TUBERCULOSIS MODEL IN MICE CAUSED BY TUBERCULOUS MYCOBACTERIA WITH EXTENSIVE DRUG RESISTANCE
title_full_unstemmed INVESTIGATION OF CO-TRIMOXAZOLE EFFICIENCY USING THE EXPERIMENTAL TUBERCULOSIS MODEL IN MICE CAUSED BY TUBERCULOUS MYCOBACTERIA WITH EXTENSIVE DRUG RESISTANCE
title_short INVESTIGATION OF CO-TRIMOXAZOLE EFFICIENCY USING THE EXPERIMENTAL TUBERCULOSIS MODEL IN MICE CAUSED BY TUBERCULOUS MYCOBACTERIA WITH EXTENSIVE DRUG RESISTANCE
title_sort investigation of co trimoxazole efficiency using the experimental tuberculosis model in mice caused by tuberculous mycobacteria with extensive drug resistance
topic экспериментальный туберкулез у мышей
туберкулез с млу/шлу возбудителя
лекарственная чувствительность m. tuberculosis к ко-тримоксазолу
url https://www.tibl-journal.com/jour/article/view/976
work_keys_str_mv AT sapopov investigationofcotrimoxazoleefficiencyusingtheexperimentaltuberculosismodelinmicecausedbytuberculousmycobacteriawithextensivedrugresistance
AT gnmozhokina investigationofcotrimoxazoleefficiencyusingtheexperimentaltuberculosismodelinmicecausedbytuberculousmycobacteriawithextensivedrugresistance
AT sakosenkov investigationofcotrimoxazoleefficiencyusingtheexperimentaltuberculosismodelinmicecausedbytuberculousmycobacteriawithextensivedrugresistance
AT naelistratova investigationofcotrimoxazoleefficiencyusingtheexperimentaltuberculosismodelinmicecausedbytuberculousmycobacteriawithextensivedrugresistance
AT tpsabgayda investigationofcotrimoxazoleefficiencyusingtheexperimentaltuberculosismodelinmicecausedbytuberculousmycobacteriawithextensivedrugresistance